CVE-2024-29129

CVE-2024-29129 is a high-severity vulnerability in Oxyextras with a CVSS 3.x base score of 7.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: from n/a through 1.4.4.

Frequently asked questions

What is CVE-2024-29129?
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: from n/a through 1.4.4.
How severe is CVE-2024-29129?
CVE-2024-29129 has a CVSS 3.x base score of 7.1, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2024-29129 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (29th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-29129?
CVE-2024-29129 affects Oxyextras. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-29129?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2024-29129 have an EU (EUVD) identifier?
Yes. CVE-2024-29129 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-26167.
When was CVE-2024-29129 published?
CVE-2024-29129 was published on 2024-03-19 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →